Your browser doesn't support javascript.
loading
Differential impact of glycemic control and comorbid conditions on the neurophysiology underlying task switching in older adults with type 2 diabetes.
Embury, Christine M; Lord, Grace H; Drincic, Andjela T; Desouza, Cyrus V; Wilson, Tony W.
Afiliación
  • Embury CM; Institute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE 68010, USA.
  • Lord GH; Department of Psychology, University of Nebraska Omaha, Omaha, NE 68182, USA.
  • Drincic AT; Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Desouza CV; Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Wilson TW; Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Aging (Albany NY) ; 14(12): 4976-4989, 2022 06 17.
Article en En | MEDLINE | ID: mdl-35714977
ABSTRACT
Type 2 diabetes is known to negatively affect higher order cognition and the brain, but the underlying mechanisms are not fully understood. In particular, glycemic control and common comorbidities are both thought to contribute to alterations in cortical neurophysiology in type 2 diabetes, but their specific impact remains unknown. The current study probed the dynamics underlying cognitive control in older participants with type 2 diabetes, with and without additional comorbid conditions (i.e., cardiovascular disease, nephropathy, peripheral neuropathy, retinopathy), using a task switching paradigm and a dynamic functional brain mapping method based on magnetoencephalography (MEG). We hypothesized that neural dynamics would be differentially impacted by the level of glycemic control (i.e., diabetes itself) and the burden of additional comorbid conditions. Supporting this hypothesis, our findings indicated separable, but widespread alterations across frontal, parietal, temporal and cerebellum regions in neural task-switch costs in type 2 diabetes that were differentially attributable to glycemic control and the presence of comorbid conditions. These effects were spatially non-overlapping and the effects were not statistically related to one another. Further, several of the effects that were related to the presence of comorbidities were associated with behavioral performance, indicating progressive deficits in brain function with extended disease. These findings provide insight on the underlying neuropathology and may inform future treatment plans to curtail the neural impact of type 2 diabetes.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Control Glucémico Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Control Glucémico Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2022 Tipo del documento: Article